7Baggers
 (APLS) Volatility Zones as Tactical Triggers  news.stocktradersdaily.com Sat, 15 Nov 2025 18:28:02 GMT
 published on: 2025-11-14 10:40:48  newser.com Fri, 14 Nov 2025 16:40:48 GMT
 published on: 2025-11-13 18:42:44  newser.com Fri, 14 Nov 2025 00:42:44 GMT
 Apellis (APLS) Reveals Promising Long-Term Results for SYFOVRE i  GuruFocus Wed, 12 Nov 2025 13:10:31 GMT
 Apellis reports SYFOVRE delays GA lesion growth by 1.5 years  Investing.com Wed, 12 Nov 2025 12:25:29 GMT
 Apellis Announces 5-Year GALE Data Showing SYFOVRE®  GlobeNewswire Wed, 12 Nov 2025 12:00:00 GMT
 using ai based signals to follow apellis pharmaceuticals inc.  newser.com Mon, 10 Nov 2025 08:35:39 GMT
 apls stock: wolfe research initiates coverage with peer perform  GuruFocus Thu, 06 Nov 2025 14:08:31 GMT
 published on: 2025-11-05 05:50:21  newser.com Wed, 05 Nov 2025 11:50:21 GMT
 published on: 2025-11-05 05:24:02  newser.com Wed, 05 Nov 2025 11:24:02 GMT
 published on: 2025-11-05 04:30:31  newser.com Wed, 05 Nov 2025 10:30:31 GMT
 price-driven insight from (apls) for rule-based strategy  news.stocktradersdaily.com Tue, 04 Nov 2025 17:12:02 GMT
 Why Apellis Pharmaceuticals Shares Are Under Pressure  TipRanks Mon, 03 Nov 2025 08:00:00 GMT

Apellis Pharmaceuticals, Inc
(NASDAQ:APLS) 

APLS stock logo

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is pegcetacoplan that is in Phase III clinical trials fo...

Founded: 2009
Full Time Employees: 350
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends